HEART FAILURE IN CHILDREN WITH SINGLE VENTRICLE. LEVEL OF BIOCHEMICAL MARKERS AFTER FONTAN PROCEDURE WITH EXTRACARDIAC CONDUIT

The aim of the study was to assess biochemical markers of myocardial injury, endothelial dysfunction, and heart failure (HF) in children with single ventricle (SV) a year after total cavopulmonary connection (TCPC) and to determine correlations of these biochemical markers with hemodynamic data before TCPC. Materials and Methods. A total of 29 patients with SV aged 3 to 16 years were involved in the study a year after TCPC with extracardiac conduit. The average patient age was 7.7 years ± 3.6 months. Patients were divided into two groups depending on HF (according to NYHA). Group 1 (NYHA I) included 13 patients; group 1 (NYHA II) included 16 patients. All patients underwent complete examination: electrocardiography (ECG), 24-hour Holter ECG monitoring, and echocardiography. Biochemical markers such as brain natriuretic peptide (BNP), N-terminal pro(B(type natriuretic peptide (NT(pro BNP), atrial natriuretic peptide (ANP), fatty acid binding protein (FABP), endothelin-1, and nitric oxide metabolite were assessed. Results. Median NT(pro BNP was elevated in group 2 [123.9 pg/mL (IQR: 52.9–370.5)]. Increased BNP level was observed in 27 children (93.1%) after Fontan procedure. Median BNP levels were elevated in both study groups [204 pg/mL (IQR:129–355) and 211 pg/mL (IQR:92–327), correspondingly]. Median endothelian-1 levels were high in both groups (44.4 (IQR: 14–100.3) and 42.3 (IQR: 6.2–155.8)]. Direct correlation relationship between NT-pro BNP level a year after TCPC and average pulmonary artery pressure before TCPC was found (r=0.54; р=0.04). Nitrogen nitrite level exceeded normal values in all patients. Significantly higher median nitrogen nitrate was found in study group 2 [22.52 (IQR: 31.47–28.95) and 27.94 (IQR: 19.84– 45.51), correspondingly], p=0.04. According to the individualized analysis, nitrogen nitrate level corresponded to normal values only in one patient with HF (NYHA II). At the same time, nitrogen nitrite level was elevated in all patients. Conclusions. NT-pro BNP and BNP levels a year after TCPC were elevated in most of the patients with SV (82.8%). The higher pulmonary artery pressure was before TCPC, the higher NT–pro BNP level was a year after the procedure (p=0.04). 

1. Patrick W. Prevalence, clinical presentation and natural history of patients with single ventricle // Prog. Pediatr. Cardiol. – 2002. – Vol. 16. – Р. 31–38.

2. Mavroudis C., Backer C.L. Pediatric cardiac surgery. – 3rd ed. – Mosby, 2003. – 875 p.

3. Moodie D.S., Ritter D.G., Tajik A.J. et al. Long(term follow(up in the unoperated univentricular heart // Am. J. Cardiol. – Vol. 53(8). – P. 1124–1128.

4. Koch A., Zin S., Singer H. B(type natriuretic peptide in paediatric patients with congenital heart disease // Eur. Heart J. – 2006. – Vol. 27(7). – P. 861–866.

5. Kantor P.F., Rusconi P. Biomarkers in pediatric heart failure: their role in diagnosis and evaluating disease progression // Progress in Pediatric Cardiology. – 2011. – Vol. 31. – P. 53–57.

6. Pincott E.S., Burch M. New biomarkers in heart failure // Progress in Pediatric Cardiology. – 2011. – Vol. 31. – P. 49–52.

7. Hsu D.T., Pearson G.D. Heart failure in children. Part I: History, etiology, and pathophysiology // Circulation: Heart Failure. – 2009. – Vol. 5. – P. 490–498.

8. Potter L.R., Yoder A.R., Flora D.R. et al. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic // Handb. Exp. Pharmacol. – 2009. – Vol. 191. – P. 341–366.

9. Tsikas D., Bцhmer A., Mitschke A., Araujo P. Accurate measurement of nitrate, nitrite, and S(nitrosothiols in biological samples by mass spectrometry // Free Radic. Biol. Med. – 2013. – Vol. 65. – Р. 301–304.

10. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids // Free Radic. Res. – 2005. – Vol. 39. – No. 8. – Р. 797–815.

11. Метельская В.А., Гуманова Н.Г. Оксид азота: роль в регуляции биологических функций, методы определения в крови человека // Лаб. медицина. – 2005. – № 7. – С. 19–24.

12. Van den Berg M.P., Tjeerdsma G., Jan de Kam P. et al. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure // Eur. J. Heart Fail. – 2002. – Vol. 4(3). – P. 255–262.

13. Gobinet(Georges A., Valli N., Filliatre H. et al. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma / / Clin. Chem. Lab. Med. – 2000. – Vol. 38(6). – P. 519–523.

14. Koch A.M., Zink S., Singer H., Dittrich S. B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection // Eur. J. Heart Fail. – 2008. – Vol. 1. – P. 60–62.

15. Wеhlander H., Westerlind A., Lindstedt G. et al. Increased levels of brain and atrial natriuretic peptides after the first palliative operation, but not after a bidirectional Glenn anastomosis, in children with functionally univentricular hearts // Cardiol. Young. – 2003. – Vol. 3. – P. 268–274.

16. Law Y.M., Ettedgui J., Beerman L. et al. Comparison of plasma B- type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure // Am. J. Cardiol. – 2006. – Vol. 98(4). – P. 520–524.

17. Anderson P.A., Sleeper L.A., Mahony L. et al. Contemporary outcomes after the Fontan procedure // J. Am. Coll. Cardiol. – 2008. – Vol. 52(2). – P. 85–98.

18. Atz A.M., Zak V., Breitbart R.E. et al. Factors associated with serum brain natriuretic peptide levels after the Fontan procedure // Congenit. Heart Dis. – 2011. – Vol. 6(4). – P. 313–321.

19. Lowenthal A., Camacho B.V., Lowenthal S. et al. Usefulness of B- type natriuretic peptide and N(terminal Pro(B(type natriuretic peptideas biomarkers for heart failure in young children with single ventricle congenital heart disease // Am. J. Cardiol. – 2012. – Vol. 109(6). – P. 866–872.

20. Mair J., Gerda F., Renate H. et al. Head-to(head comparison of B(type natriuretic peptide (BNP) and NT(proBNP in daily clinical practice / Int. J. Cardiol. – 2008. – Vol. 124(2). – P. 244– 246.

21. Willey K.E., Davenport A.P. Nitric oxide-medulation of the endothelin-1 signaling pathway in the human cardiovascular system // Br. J. Pharmacol. – 2001. – Vol. 132(1). – P. 213–220.

22. Katayama T., Yano K., Nakashima H. et al. Clinical significance of acute-phase endothelin-1 in acute myocardial infarction patients treated with direct coronary angioplasty // Circ. – 2005. – Vol. 69(6). – P. 654–658.

23. Рябов В.В., Суслова Т.Е., Марков В.А. Определение белка, связывающего жирные кислоты, в диагностике острого инфаркта миокарда // Бюл. СО РАМН. – 2005. – №. 3 – С. 26–29.

24. Hermens W.T. Mechanisms of protein release from injured heart muscle // Dev. Cardiovasc. Med. – 1998. – Vol. 205. – P. 85–98.

25. Wodzig K.W., Kragten J.A., Modrzejewski W. et al. Thrombolytic therapy does not change the release ratios of enzymatic and nonenzymatic myocardial marker proteins // Clin. Chim. Acta. – 1998. – Vol. 272(2). – P. 209–223.

26. Hassan M.E. Azzazy, Christenson Maurice M.A.L. Unbound Free Fatty Acids and Heart-Type Fatty Acid(Binding Protein: Diagnostic Assays and Clinical Applications // Clin. Chem. – 2006. – Vol. 52(1). – P. 19–29.

27. Tambara K., Fujita M., Miyamoto S. et al. Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H(FABP) is an indicator of severe myocardial ischemia // Int. J. Cardiol. – 2004. – Vol. 93(2–3). – P. 281–284.

28. Эрлих А.Д., Катруха А.Г., Трифонов И.Р. и др. Острый коронарный синдром без подъемов сегмента ST на ЭКГ. Прогностическое значение определения сердечной формы белка, связывающего жирные кислоты. Результат 12-месячного наблюдения // Кардиология. – 2005. – № 5. – С. 13– 21.

29. Glatz J.F., Kleine A.H., Van Nieuwenhoven F.A. et al. Fatty-acid- binding protein as a plasma marker for the estimation of myocardial infarct size in humans // Br. Heart J. – 1994. – Vol. 71(2). – P. 135–140.

30. Sun Yu-Ping, Wang Wen(Di, Ma Shao(Chun et al. Changes of heart type fatty acid(binding protein in children with chronic heart failure and its significance // Chin. J. Contemp. Pediatr. – 2013. – Vol. 15(2). – P. 99–101.